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Abstract 
Prophet Muhammad (SWS) once stated that habbatus sauda (black seed) can heal every disease except death. To our 
knowledge the effect of this seed on autoimmunity process has never been examined.This study was carried out in 
UiTM Malaysia to investigate the potential immunomodulatory effect of administration of the major component of 
Habbatus Sauda; (Thymoquinone) in the autoimmune disease process of type 1 diabetes mellitus as a common 
example of autoimmune diseases. We have evaluated with the help of ELISA kits the levels of anti- islet cell 
autoantibodies (ICA), Pan T lymphocytes marker, Pan B lymphocytes marker, and Pan innate cells marker in male 
Sprague-Dawley rats with Streptozocin-induced the autoimmune disease process of type 1 diabetes mellitus. The four 
groups (6 rats each) under study received or not different doses of Thymoquinone. The results have been compared to 
the ones obtained from healthy and non treated diabetic rats. The administration of Thymoquinone especially in high 
doses to the type1 diabetic rats leads to a significant decreases in the levels of all immunological parameters and stop 
the disease process (p<0.001). The data may provide new strategies about Habbatus Sauda to be recommended in the 
clinical management of autoimmune diseases as one of documented halal prescription.  
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1. Introduction 
 
        The immune system defends the body against infections and certain other diseases. It is made up of 
different organs, cells, and proteins known as antibodies. It identifies, attacks, and destroys germs and 
other foreign substances. Sometimes the immune system makes a mistake and attacks the body's own 
tissues or organs. This is called autoimmunity. Any disease that results from such an aberrant immune 
response is termed an autoimmune disease.  Autoimmune diseases can strike any part of the body, thus 
symptoms vary widely and diagnosis and treatment are often difficult. (Stefanova I., et al 2002)  One 
common example of an autoimmune disease is type 1 diabetes mellitus (IDDM), in which the immune 
system destroys the cells in the pancreas that produces insulin. 
 
1.1 Literature review 
 
         IDDM or insulin-dependent diabetes mellitus is an autoimmune disease process in which pancreatic 
islet β-cells are targeted for destruction by an aberrant host immune system (American Diabetes 
Association 2008). This process involves both the cellular and humoral branches of the immune system, 
with the generation of islet-specific T-cell reactivity, as well as autoantibodies directed against islet cell 
antigens known as anti islet cell antibodies (ICA). In subjects newly diagnosed with IDDM, up to 90% 
have antibodies to ICA. (Notkins AL. and Lernmark Å. 2001). These autoantibodies appear during the 
preclinical period of β-cell destruction before the clinical manifestation of diabetes (Notkins AL. and 
Lernmark Å. 2001).  
        Experimental studies on animals especially rats showed that these animals develop a form of 
autoimmune diabetes that resembles human IDDM (American Diabetes Association 2008). Studies with 
animal model have established that islet-infiltrating cell– reactive T-cells are the major effectors of ß-cell 
damage. However, other immune system cells are also crucial in the disease development. Among these 
cells, B-cells are essential in the onset and progression of type 1 diabetes (Bach, J.F., 1994, Pietropaolo M 
and Pugliese A, 2000), and although it is not fully understood when and how these cells participate in 
IDDM, it is known that they produce ICA autoantibodies against many ß-cell autoantigens (Pietropaolo 
M. and Pugliese A, 2000) and act as antigen-presenting cells (Tisch R. and McDevitt HO 1996). On the 
other hand, the production of specific ICA autoantibodies directly correlates with the progression of 
IDDM in both humans and laboratory animals. (Tisch R. and McDevitt HO 1996, Kikutani H. and 
Makino S. 1992). 
        Natural immunomodulators are going to be a central part of 21st medicine helping the body help 
itself by optimizing the immune system is of central importance in a society so stressed, unhealthily 
nourished and exposed to toxins that most of poeples are likely to have compromised immune systems 
(U.S. Patil et al 2010).  Immunomodulation, however, is a normalizing process, which correct weak or 
abnormal  immune systems and temper immune systems that are overactive. Immunomodulators are 
becoming a viable adjunct to established modalities offering a novel approach for the treatment of 
immunological diseases in the coming decades of 21
st
 century (U.S. Patil et al 2010). Among these 
natural immunomodulators is the black seeds. 
      The black seeds (habbatus sauda) of the Nigella sativa (NS) plant that belongs to the Ranunculaceae 
plant family have an extensive history of medicinal use that dates back thousands of years as a spice and 
food preservative. The black seeds and oil have shown potential medicinal properties in traditional 
medicine and was used by physicians to treat an assortment of illnesses, however Prophet of Islam; 
Muhammad (sws) once stated the black seed can heal every disease except death (Atta, M.B. 2003). 
Contemporary naturopathic medicine around the world has used NS and its major component 
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Thymoquinone (TQ) as a diuretic, carminative, treatment for asthma, bronchospasm, coughs, back pain, 
hypertension and obesity  (Atta, M.B. 2003,  Salem, M.L. 2005). 
       Thymoquinone has been proven that exerts anti-inflammatory, anti-bacterial and immunomodulatory 
effects (Salem, M.L. 2005, Swamy, S.M. and B.K. Tan 2000, Ragheb, A. et al 2009). The biological 
activity of the active principle explains the beneficial effects of black seeds or TQ in the treatment of 
human patients with allergic diseases (Kalus, U. et al 2003, Isik, H. et al 2010), asthma (Boskabady, M.H.. 
et al 2007) or tonsillopharyngitis (Dirjomuljono, M. et al 2008). In induced animal models, the 
administration of TQ was effective against rheumatoid arthritis (Tekeoglu, I. et al 2007) and autoimmune 
encephalomyelitis (Mohamed, A. et al 2009). Studies with rats and mice have demonstrated that extracts 
of black cumin seed have antibacterial (Hanafy, M.S. and M.E. Hatem, 1991), anti-viral (Salem, M.L. and 
M.S. Hossain, 2000) and anti-parasite activity (Ayaz, E. et al 2007). 
        Due to the increasing worldwide prevalence and financial burden of some autoimmune diseases 
like type 1 diabetes, it has become increasingly important to find pharmacological remedies to alleviate 
the symptoms and complications of these conditions.  However, to date, there are no successful 
treatment interventions that have been found to delay the onset of IDDM. Meanwhile, several studies 
have been carried out to explain the controversial effect of TQ on the non-specific immune responses in 
IDDM but the exact role on the disease process still unclear. Thus, our present study was carried out in 
UiTM Malaysia to investigate the potential immunomodulatory effect of  administration of the major 
component of Habbatus Sauda; Thymoquinone in the autoimmune disease process of type 1 diabetes 
mellitus as a common example of autoimmune diseases by determination its effect on the levels of main 
immunological cell markers in IDDM: autoimmune anti- islet cell antibodies (ICA), pan T- lymphocytes 
marker (CD90), pan B-lymphocytes marker (CD19), and pan innate cells marker (CD11b).  
 
2. Materials & Methods  
 
2.1. Experimental animals 
       Twenty four male Sprague-Dawley rats with an average weight of 150-250g and an average age of 
12-16 weeks were used throughout the experiment. The rats were acclimatized for a period of 21 days. A 
standard environmental condition such as temperature (20-22 0C), relative humidity (45-55%) and 12 hrs 
dark/light cycles was maintained. The animals were fed daily with rodent pellet diet and tap water ad-
libitum under strict hygienic conditions. Ethical clearance for performing the experiment on animals was 
approved by Animal Care and Use Committee (ACUC), Faculty of Medicine, Universiti Teknologi 
MARA (UiTM) Malaysia that conforms to the Guide for the Care and Use of Laboratory Animals (Axel 
V et al 1994), and all efforts were made to minimize animal suffering and the number of animals used. 
 
2.2. Chemicals 
   Streptozotocin (STZ) and Thymoquinone TQ used in the present study were purchased from Nano Life 
Quest Company; Thymoquinone TQ (2-isopropyl-5-methyl-1,4-benzoquinone, C10H12O2).  The TQ was 
administered once a day by intraperitoneal injection (i.p) at a dose of (5 mg/kg and 10mg/kg) for 30 days.  
      
2.3. Induction of type 1 diabetes mellitus and treatment of rats 
 
      A single injection of STZ is widely used to generate a rat model of type I diabetes, which results from 
the selective toxicity of STZ towards the insulin-producing β-cells in pancreatic islets (Rerup CC. 1970, 
Junod A. et al, 1969). IDDM was induced in overnight fasted animal group by i.p injection with a single 
dose of STZ (65 mg/kg body weight) (Sigma). This dose of STZ lies within the range used in most of 
studies to produce IDDM, in which blood glucose levels are 3–4 times normal, by causing substantial 
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depletion of pancreatic insulin (Alison M Gurney and Frank C Howarth  2009) .  STZ was dissolved in 
sodium citrate buffer solution (PH 4.5) immediately before use.  The development of IDDM was 
confirmed by the presence of hyperglycemia with blood glucose above 13.9mmol/L (250 mg/dL), which 
last for at least three days.  The rats were divided into four groups comprising 6 rats each. Group A (GA; 
control group), rats were injected with an equal volume of vehicle (citrate buffer, 65 mg/ Kg body weight) 
;  Group B (GB; untreated STZ-diabetic rats) ; Group C (GC; STZ-diabetic rats treated with 5 mg⁄ kg, i.p., 
TQ) ; Group D (GD; STZ-diabetic rats treated with10 mg⁄ kg, i.p.,TQ). 
       The treatment by TQ was started for a period of 30 days. During this period, Control and STZ-treated 
animals had free access to standard diet and water until 6pm. None of the rats was treated with insulin at 
any time during the experiment. Animals were sacrificed at 30th day of experiment immediately after 
measuring blood glucose (Junod A. et al  1969).   Blood glucose levels were tested every morning (at 8 
am). Blood was collected from the tail of fasting (14 h) animals. A drop of blood was used for the blood 
glucose test with the help of a One Touch Glucometer GX.  
 
2.4. Laboratory tests 
          On the last day (30th day) and after completion of the experimental protocols, blood samples were 
collected from overnight fasting rats by sacrificing each diabetic and control rats. The animals were 
anesthetized in a chamber containing diethyl ether.  Cardiac puncture was done using a heparin syringe 
and blood was collected into a heparin containing container. Immediately after collection, 2.0 ml of blood 
was transferred into fresh tube and centrifuged at 3000 rpm for 10 minutes. The serum was collected and 
stored at – 80°C until serological analysis. 
      Serum was assayed for autoimmune anti- Islet cell antibodies (ICA), pan T- lymphocytes marker 
(CD90), pan B-lymphocytes marker (CD19), and pan innate cells marker (CD11b) in addition to serum 
insulin using enzyme-linked immunosorbent assay (ELISA) by using a commercially available kits 
(USCNK, CHINA).  
2.5. Summary of ELISA method: 
     The plate was coated with a capture antibody and a sample was added, and any antigen present in a 
sample will be bind to capture antibody. The detecting antibody will be added, and binds to antigen. 
Substrate will be added and converted by the detecting antibody to detectable form.    
 
2.6. Statistical analysis  
   
       The data are expressed as mean ± SE. with 'n' referring to the number of rats used. Two way analysis 
of variance (ANOVA) was carried out using SPSS 16 software to assess the overall effects and 
interaction of treatment and time on parameters and followed by repeat one way analysis of variance 
(ANOVA) with post hoc least significant difference (LSD) test to determine the effect of treatments on 
differences among means when the analysis of variance indicated a significant result. P < 0.05 was taken 
to indicate significance. 
 
 
3. Results 
 
     The diabetic animals exhibited consistent hyperglycemia while, TQ treatment caused a decrease in the 
elevated serum glucose, and an increase (P=0.001) in the lowered serum insulin concentrations in STZ 
induced diabetic rats by the end of the experiment. (Figure 1) 
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     After induction of IDDM, the diabetic animals showed increase the levels of anti islet cell auto 
antibodies ICA. However, by the end of the experiment the TQ treatment specially in high doses diabetic 
group significantly (P= 0.001) caused decreased in elevated ICA levels (Figure 2). The same effect was 
noticed with other immunological markers (CD19, CD90, and CD11) which increased after diabetic 
induction but by the end of the experiment, TQ treatment significantly caused decrease in all elevated 
markers ( Figures 3, 4, and 5 respectively).  
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Fig.1. Effect of TQ administration on insulin level production. 
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Fig. 2. Effect of TQ adminstration on the ICA levels   
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Fig. 3. Effects of TQ adminstration on the levels of CD19 
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Fig 4. The effects of TQ administration on the levels of CD90 
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Fig 5. The effects of TQ administration on the levels of CD11 
 
4. Discussion  
 
      This study demonstrates for the first time, to our knowledge, the effect of thymoquinone TQ; the 
major component of habbatus sauda (Nigella sativa) on the autoimmune disease process in  IDDM. 
     Our principal findings are: (1) daily intraperitoneal administration of TQ (both low dose 5 mg/kg or  
high dose 10 mg/kg but more with high dose) for up to 30 days to type1 diabetic rats effectively reduces 
levels of anti islet cell antibodies ICA which are the main antibodies produced in autoimmune process of 
the disease; and (2) the elevated pan B cell marker (CD19), elevated pan T cell marker (CD90) and 
elevated pan innate cell marker (CD11) that increased due to autoimmunity process were significantly  
reduced after the administration of TQ; (3) reduced level of insulin due to damaged Langerghans islet cell 
was significantly increased in the serum due to repairing tissue process after TQ treatment.  
       While the therapeutic anti diabetic effects of TQ on type 2 diabetes mellitus are numerous and well-
documented, evidence presented in this study actually shows a novel immunomodulatory effect of TQ in 
IDDM of STZ induced diabetic rats. This finding is made more interesting by the fact that many studies 
(Al-Hader AA, e al 1993, Bamosa AO, et al 1997, El-Dakhakhny M, et al 2002b).   have shown that TQ 
is hypoglycemic in both types of diabetes through biochemical evidences while in this study we have 
proved that TQ has significant effect on the production of main autoimmune antibodies in IDDM  in 
addition to its effects on the levels of other immunological markers as well, that  lead to affect and stop 
the disease autoimmune process of IDDM. 
       Researchers have determined that during the first stage of IDDM, ICA antibodies are synthesized that 
act against the insulin-producing cells of the pancreas (Pietropaolo M, Eisenbarth GS. 2001). The 
consequence of these autoantibodies is a destruction of the insulin-producing beta cells of the islets of 
Langerhans’ cells and an absence or deficiency of circulating insulin (Al-Hader AA, e al 1993). Indirect 
immunofluorescence stains of human pancreas sections demonstrate that majority of recently diagnosed 
diabetics have ICA. (Pietropaolo M, Eisenbarth GS. 2001). The autoimmune attack of these antibodies 
appears to destroy ß cells selectively. (Al-Hader AA, e al 1993, Bamosa AO, et al 1997, El-Dakhakhny M, 
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et al 2002b, Pietropaolo M, Eisenbarth GS. 2001). Researchers have considered that ICA serum 
autoantibodies are an important hallmark of this disease, and assays for these islet cell antibodies have 
facilitated the investigation and understanding of several facets in the pathogenesis of autoimmune 
diabetes. Their applications have begun to extend into clinical practice and have opened new avenues for 
early preclinical prediction and preventive prophylaxis in IDDM. (Bamosa AO, et al 1997,  Pietropaolo 
M, Eisenbarth GS. 2001).  
      The effect of black seed or habbatus sauda on the immune system has been investigated by several 
researchers (El-Dakhakhny M, et al 2002b; Houghton PJ, et al 1995; Haq A, et al 1995; Al-Ghamdi MS. 
2001). All studies have shown that the oil and its most abundant component, TQ, inhibit many 
inflammatory mediators, and, thus, may be useful in ameliorating inflammatory and immune conditions. 
The seeds were found to produce an increase in the ratio of helper to suppressor T cells and to enhance 
natural killer cell activity in normal volunteers (El-Kadi A, et al 1987).  Moreover, in vitro studies 
showed that the TQ were potent inhibitors of eicosanoid generation, namely thromboxane B2 and 
leucotriene B4, by inhibiting both cyclooxygenase and lipoxygenase, respectively (Houghton PJ, et al 
1995). Thromboxane B2 has been implicated in the mechanism of hepatocyte plasma membrane bleb 
formation, which is an early event in hepatocyte injury when exposed to oxidative stress (Horton AA and 
Wood JM. 1990). In another study, N. sativa enhanced the production of IL-3 by human lymphocytes and 
had a stimulatory effect on macrophages (Haq A, et al 1995).  Besides, the immunomodulatory effect of 
black seed and TQ was found in mixed lymphocyte cultures and caused increased secretion in the levels 
of the cytokines IL-1b and IL-8 (Haq A, et al 1999).  Moreover, the fixed oil increased the release of 
PGE2, inhibited the release of leukotrienes and histamine from normal and sensitized guinea pig lungs. 
Other pieces of evidence include the inhibition of TNF-a production in murine septic peritonitis by TQ 
(El-Dakhakhny M, et al 2002b) and the unique immunomodulatory properties of the ethyl acetate (CC-5) 
fraction of N. sativa at non-cytotoxic doses (Salem, M.L., 2005). The ability of TQ to modulate cytokines 
and enhance the immune system has been implicated as the main reason for its protective effect against 
schistosome egg infection in the liver (Mahmoud MR, et al 2002).  However, the antiinflammatory effect 
of black seed including TQ  has been found to be comparable to that of 100 mg/kg aspirin (Al-Ghamdi 
MS. 2001). 
      In addition to the  immunological effect on the autoimmunity process of IDDM, the present study 
showed additional biochemical evidence. This result indicates that TQ affects blood glucose and insulin 
level. TQ ameliorated blood glucose and insulin levels in the present study, in accordance with data 
reported previously (Al-Hader AA. et al 1993; Bamosa AO, et al 1997; El-Dakhakhny M, et al 2002b). 
The significant increase in insulin level after TQ treatment was attributed to the antioxidant activity of TQ, 
which may alleviate damage to ß-cells in the pancreas caused by STZ (El-Dakhakhny M, et al 2002b). 
Moreover TQ was effective for ß-cell protection and prevention of IDDM initiated after injection of a 
certain dose of STZ, by down regulation of immunological inflammatory activity towards  ß -cells 
mediated by nitric oxide (Al-Hader AA et al 1993, Bamosa AO, et al 1997). 
      The goals of treatment of autoimmune diseases are to reduce symptoms, control the autoimmune 
process and maintain the body's ability to fight disease  (Goronzy JJ and Weyand CM. 2007)  Some 
patients may need supplements to replace a hormone (like insulin injections in IDDM ) (Bangstad HJ, et 
al 2009)  or immunosuppressive medicines include corticosteroids to control or reduce the immune 
system's response, but these  medicines are often cause a lot of side effects (Goronzy JJ and Weyand CM. 
2007).  Meanwhile using black seeds to treat diseases have been shown to cause no toxicity symptoms for 
both animals and humans (Al-Homidan A, et al 2002).    
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5. Conclusion  
In conclusion, these experimental results indicate the immunomodulatory effect of TQ “the major 
component of habbatus sauda” against autoimmune reactions occurs in IDDM, since the immune defense 
in this disease can be significantly improved by the administration of this plant. According to our 
knowledge; the preliminary data of our study provide for the first time a new strategy for using TQ  as a 
natural and halal product to be recommended in the clinical management, control, and prevention of 
T1DM. Moreover, these data may open a wide field to study the effect of TQ on all autoimmune diseases 
in general.   
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